| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner
3 companies
Casdin Capital, LLC is a Director, 10% Owner at GeneDx Holdings Corp. with holdings across 3 companies. Recent SEC Form 4 filings include 13 buys and 1 sell.
Estimated insider holdings value: $127.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | WGS Genedx Holdings Corp. | Director, 10% Owner | Sell | 500,000 | $120.90 | $60,451,950.00 | -14.3% | +4.2% | - | |
| Jun 4, 2024 | WGS Genedx Holdings Corp. | Director, 10% Owner | Buy | 130,000 | $21.21 | $2,757,117.00 | +2.2% | +27.5% | +200.4% | |
| May 29, 2024 | WGS Genedx Holdings Corp. | Director, 10% Owner | Buy | 40,000 | $21.07 | $842,604.00 | +1.4% | +67.1% | +230.9% | |
| May 28, 2024 | WGS Genedx Holdings Corp. | Director, 10% Owner | Buy | 170,000 | $20.15 | $3,424,989.02 | +2.0% | +73.4% | +241.1% | |
| May 13, 2024 | WGS Genedx Holdings Corp. | Director, 10% Owner | Buy | 50,000 | $23.31 | $1,165,295.00 | +1.8% | +43.2% | +160.6% | |
| Mar 5, 2024 | WGS Genedx Holdings Corp. | Director, 10% Owner | Buy | 40,900 | $8.74 | $357,652.30 | +0.8% | +145.7% | +1106.3% | |
| Jun 16, 2020 | GBIO Generation Bio Co. | 10% Owner | Buy | 650,000 | $19.00 | $12,350,000.00 | +67.6% | - | - | |
| Jul 22, 2019 | FULC Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 140,000 | $15.84 | $2,217,495.00 | +8.5% | - | - |